Update on Availability of Cancer Care Centres

Now I have enough (4+ Tier-1 facts). Writing the note.

Update on Availability of Cancer Care Centres in India

1. At a Glance

2. Why in the News

3. Background & Evolution

4. Core Static Facts

Parameter Detail
Nodal Ministry Ministry of Health & Family Welfare (MoHFW) [S1]
Parent programme NP-NCD under National Health Mission [S1]
District NCD Clinics 770 set up nationally [S1]
Day Care Cancer Centres (DCCCs) 524 [S1]
NCD Clinics at CHCs 6,410 [S1]
State Cancer Institutes (SCIs) approved 19 [S1]
Tertiary Care Cancer Centres (TCCCs) approved 20 [S1]
One-time grant — SCI Up to ₹120 crore (incl. State share) [S3]
One-time grant — TCCC Up to ₹45 crore (incl. State share) [S3]
AB PM-JAY cover 1,961 procedures, 27 specialties, ₹5 lakh/family/year, cashless via empanelled public & private hospitals [S1]
Screened NCDs at AAM Hypertension, Diabetes, Oral Cancer, Breast Cancer, Cervical Cancer [S2]
Target group for cancer screening Persons aged 30+ years [S2]
AAMs operationalised (till 31.10.2025) 1,80,906 [S2]
Apex national institute National Cancer Institute (NCI), Jhajjar (under AIIMS Delhi) [S1]
Kolkata apex institute Chittaranjan National Cancer Institute (CNCI) — second campus [S1]

5. Multi-Dimensional Analysis

Social - Focus on 30+ population and population-based screening targets equity in early detection, particularly for women (breast, cervical cancer) [S2]. - Rural-urban gap persists — DCCCs and TCCCs remain concentrated in State capitals/tier-1 cities.

Administrative - Scheme design follows Centre-State cost-sharing (grants "including State share"), meaning implementation pace depends on State compliance and utilization capacity [S3]. - Human resource shortage (oncologists, radiotherapists) is the binding constraint even where infrastructure grants are sanctioned.

Economic - AB PM-JAY reduces catastrophic out-of-pocket expenditure for high-cost oncology procedures (radiation, chemotherapy) [S1]. - One-time capital grants (₹45–120 crore) build infrastructure but recurring operational costs fall on States.

Governance/Ethical - Reliance on empanelled private hospitals under PM-JAY raises quality-assurance and fraud-control concerns in cashless claims.

Scientific/Technological - Screening data (crore-level figures for oral/breast/cervical cancer tests) reflects a shift toward population-based, technology-enabled early detection via AAMs [S2].

6. Recent Developments (last 12-18 months)

7. Prelims Hooks

8. Mains Relevance

9. Related Topics to Study Next

10. Common Errors / Trap Areas

11. Sources